Announcements Trials
Browse Landscape

Phase

Phase 2 52Phase 1 52Phase 1/2 20Phase 3 5Phase NA 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Withdrawn 1Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × temsirolimus × Clear all
NCT01404104 2016-07-27

Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

St. Joseph's Healthcare Hamilton

Phase NA Completed
11 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00235794 2007-12-27

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Wyeth is now a wholly owned subsidiary of Pfizer

Phase NA Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡